The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?
Open accessAbstract
Background: Human umbilical cord mesenchymal stem cells (HUC-MSCs) present in the umbilical cord tissue are self-renewing and multipotent. They can renew themselves continuously and, under certain conditions, differentiate into one or more cell types constituting human tissues and organs. HUC-MSCs differentiate, among others, into osteoblasts, chondrocytes, and adipocytes and have the ability to secrete cytokines. The possibility of noninvasive harvesting and low immunogenicity of HUC-MSCs give them a unique advantage in clinical applications. In recent years, HUC-MSCs have been widely used in clinical practice, and some progress has been made in their use for therapeutic purposes. Main body: This article describes two aspects of the clinical therapeutic effects of HUC-MSCs. On the one hand, it explains the benefits and mechanisms of HUC-MSC treatment in various diseases. On the other hand, it summarizes the results of basic research on HUC-MSCs related to clinical applications. The first part of this review highlights several functions of HUC-MSCs that are critical for their therapeutic properties: differentiation into terminal cells, immune regulation, paracrine effects, anti-inflammatory effects, anti-fibrotic effects, and regulating non-coding RNA. These characteristics of HUC-MSCs are discussed in the context of diabetes and its complications, liver disease, systemic lupus erythematosus, arthritis, brain injury and cerebrovascular diseases, heart diseases, spinal cord injury, respiratory diseases, viral infections, and other diseases. The second part emphasizes the need to establish an HUC-MSC cell bank, discusses tumorigenicity of HUC-MSCs and the characteristics of different in vitro generations of these cells in the treatment of diseases, and provides technical and theoretical support for the clinical applications of HUC-MSCs. Conclusion: HUC-MSCs can treat a variety of diseases clinically and have achieved good therapeutic effects, and the development of HUC-MSC assistive technology has laid the foundation for its clinical application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sun, G., Li, G., Li, D., Huang, W., Zhang, R., Zhang, H., Duan, Y., & Wang, B. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.04.006 · Cited by 314
Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro
Zhang, L.-T., Peng, X.-B., Fang, X.-Q., Li, J.-F., Chen, H., & Mao, X.-R. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3500 · Cited by 29
Huang, Z.-W., Liu, N., Li, D., Zhang, H.-Y., Wang, Y., Liu, Y., Zhang, L.-L., & Ju, X.-L. (2017) · Yonsei Medical Journal · doi:10.3349/ymj.2017.58.1.206 · Cited by 25
Cited by
Effects, methods and limits of the cryopreservation on mesenchymal stem cells
Wang, J., & Li, R. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03954-3 · Cited by 40
Qin, D., Wang, C., Li, D., & Guo, S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105487 · Cited by 27
Xiong, Z., Chen, P., Wang, Z., Yao, L., Yuan, M., Liu, P., Sun, M., Shu, K., & Jiang, Y. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.02.045 · Cited by 14
Pretreatment of UC-MSCs with IFN-α2 improves treatment of liver fibrosis by recruiting neutrophils
Xie, Y., Yao, J., Yan, M., Lin, Y., Wei, J., Wang, H., Mao, Y., Liu, P., & Li, X. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04732-0 · Cited by 9
Metadata
- Authors
- Xie, Q., Liu, R., Jiang, J., Peng, J., Yang, C., Zhang, W., Wang, S., & Song, J.
- Venue
- Stem Cell Research & Therapy
- Published
- 2020-12
- Volume
- 11
- Issue
- 1
- Pages
- 519-519
- ISSN
- 1757-6512 (ISSN-L)
- OpenAlex
- W3109409752
- Cited by
- 252
- References
- 3
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? https://app.cochat.ai/papers/10.1186/s13287-020-02011-z
- The paper
- Xie, Q., Liu, R., Jiang, J., Peng, J., Yang, C., Zhang, W., Wang, S., & Song, J. (2020). What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-020-02011-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.